vida: extract claims from 2026-05-01-npr-nebraska-medicaid-work-requirements-day-one
- Factual accuracy — The claims appear factually correct, with the Nebraska implementation details aligning with the broader projections and mechanisms described.
- Intra-PR duplicates…
vida: extract claims from 2026-05-01-npr-nebraska-medicaid-work-requirements-day-one
vida: extract claims from 2026-04-24-compass-pathways-fda-rolling-nda-priority-voucher-comp360
- Factual accuracy — The claims regarding the COMP360 trials, response rates, and FDA actions appear factually correct based on the provided source.
- Intra-PR duplicates — There are…
vida: extract claims from 2026-04-24-arpa-h-evident-139m-behavioral-health-psychedelics
- Factual accuracy — The claims appear factually correct, describing a hypothetical future scenario based on current trends in psychedelic research and policy.
- Intra-PR duplicates…
vida: extract claims from 2026-04-24-compass-pathways-fda-rolling-nda-priority-voucher-comp360
vida: extract claims from 2026-04-24-arpa-h-evident-139m-behavioral-health-psychedelics
vida: extract claims from 2026-03-27-rwjf-stateline-medicaid-work-requirements-coverage-loss-projections
- Factual accuracy — The claims appear factually correct, supported by the cited sources (RWJF/Stateline, CBO, CBPP, AMA, Urban Institute).
- Intra-PR duplicates — There are no…
vida: extract claims from 2026-02-18-medrxiv-oregon-psilocybin-services-mental-health-outcomes
- Factual accuracy — The claims are factually correct, supported by the provided sources regarding the Bendable Therapy Oregon study and Oregon Measure 109.
- Intra-PR duplicates —…
vida: extract claims from 2026-03-27-rwjf-stateline-medicaid-work-requirements-coverage-loss-projections
vida: extract claims from 2026-02-18-medrxiv-oregon-psilocybin-services-mental-health-outcomes
vida: extract claims from 2025-12-12-utmb-uthealth-texas-ibogaine-impact-50m-oud
- Factual accuracy — The claims appear factually correct, aligning with current understanding of ibogaine's efficacy and safety concerns, as well as the political landscape surrounding…
vida: extract claims from 2025-07-03-opb-oregon-psilocybin-clients-wealthier-sb303-data
- Factual accuracy — The claims regarding the COMP005 trial design and the cost structure of psilocybin therapy are factually correct based on the provided sources.
- *Intra-PR duplicates…
vida: extract claims from 2025-12-12-utmb-uthealth-texas-ibogaine-impact-50m-oud
vida: extract claims from 2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey
- Factual accuracy — The claims appear factually correct, drawing data from the specified source regarding Oregon's psilocybin program and Compass Pathways' trial.
- Intra-PR duplicates…
vida: extract claims from 2025-07-03-opb-oregon-psilocybin-clients-wealthier-sb303-data